Ads
related to: dvd for myeloma treatment options after relapse surgery cost- Disease Overview
Learn About Disease And Treatment
Progression For RRMM.
- Dosing Schedule
Find More Information On Dosing.
Create A Treatment Calendar.
- Combination Therapy
Understand Triplet
Combination Therapy.
- Triplet Data
Access Important Safety Data
For This Treatment Option.
- Nurse Dosing Resources
View Nurse Resources & Tools.
Download A Medication Guide.
- Renal Dosing
View Dosing Information Based
On Renal Impairment.
- Disease Overview
Search results
Results From The WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone. [8] It is taken by mouth. [8]
Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. [6] Often, no symptoms are noticed initially. [10] As it progresses, bone pain, anemia, renal insufficiency, and infections may occur. [10]
Belantamab mafodotin is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.
Doctors said that’s a result of better treatment options, and may even be an underestimate given the new drugs available. In many cases, people with multiple myeloma are still able to pursue ...
MDS after exposure to DNA topoisomerase II inhibitors occurs after a shorter latency of only 1–3 years and can have a 11q23 translocation. Other pre-existing bone-marrow disorders such as acquired aplastic anemia following immunosuppressive treatment and Fanconi anemia can evolve into MDS. [15]
MMRF was founded in 1998 by twin sisters Kathy Giusti and Karen Andrews, following Kathy's diagnosis with multiple myeloma. Giusti, a pharmaceutical company executive and Harvard Business School Alum, wanted to encourage researchers to develop treatments for multiple myeloma by using business models rather than academic models of drug development .
Ads
related to: dvd for myeloma treatment options after relapse surgery cost